fbpx
  1. Home

Jenner Institute

Oxford’s Vaccitech completes IPO on Nasdaq and raises $110.5m
Life Sciences

Oxford’s Vaccitech completes IPO on Nasdaq and raises $110.5m

The Oxford-based clinical-stage biopharmaceutical company that co-invented a COVID-19 vaccine is a spin-out from Oxford University’s Jenner Institute.